Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621569 · ClinicalTrials.gov registry record · NA
ADAPT-Altering Diet for African American Populations to Treat Hypertension
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT00621569 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 122 participants.
The verdict
NCT00621569, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
The purpose of the study is to develop a culturally appropriate DASH intervention and test the effectiveness of the intervention lower blood pressure in a group of African American participants at risk for developing hypertension (pre-hypertension) and those with mild hypertension (stage I).
Interventions
- BEHAVIORAL Dietary Approaches to Stop Hypertension-The DASH diet
- BEHAVIORAL Intervention with no dietary component - information regarding useful life skills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2005-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621569
The ClinicalTrials.gov registry entry for NCT00621569 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dietary Approaches to Stop Hypertension-The DASH diet is the first listed.
NCT00621569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00621569 about?
NCT00621569 is a clinical study titled "ADAPT-Altering Diet for African American Populations to Treat Hypertension". The purpose of the study is to develop a culturally appropriate DASH intervention and test the effectiveness of the intervention lower blood pressure in a group of African American participants at risk for developing hypertension (pre-hypertension) and those with mild hypertension (stage I).
What is the current status of trial NCT00621569?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2005-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00621569?
The interventions under investigation include: Dietary Approaches to Stop Hypertension-The DASH diet (BEHAVIORAL), Intervention with no dietary component - information regarding useful life skills (BEHAVIORAL).
Who is sponsoring clinical trial NCT00621569?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.